Anchor Therapeutics

Home     Sitemap      Contact

 

Anchor's pepducin platform

Anchor Therapeutics designs and develops peptide modulators of G protein-coupled receptors (GPCRs), the largest family of drug targets. Anchor’s peptides, called pepducins, modulate GPCR activity utilizing a unique intracellular allosteric mechanism that is well suited for a wide variety of targets, including intractable and orphan receptors. Anchor and its pharma collaborators are leveraging the broad applications of pepducin technology to create new treatment options for regenerative medicine, diabetes, inflammation and cancer. 

 

 

 

 

 

 

Copyright 2012 Anchor Therapeutics. All Rights Reserved.    Privacy Policy    Terms Of Use